PELTHOS THERAPEUTICS INC.

Profile

Company Names

PELTHOS THERAPEUTICS INC.
CHROMOCELL THERAPEUTICS CORP

Addresses

4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC 27703

4400 ROUTE 9 SOUTH, SUITE 1000, FREEHOLD, NJ 07728

Phone Numbers

919-908-2422
(877) 265-8266

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$68,850,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-11-06 
$18,000,000.00 
$18,000,000.00 
$0.00 
 
2
2025-07-01 
$50,100,000.00 
$50,100,000.00 
$0.00 
Equity 
1
2024-07-24 
$750,000.00 
$750,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
 
BAXTER 
DIRECTOR
PELTHOS THERAPEUTICS INC.   |  EQUITY RISK SCIENCES, INC.
TODD 
 
DAVIS 
DIRECTOR
LIFELOCK, INC.   |  NURON BIOTECH, INC.   |  LIGAND PHARMACEUTICALS INC   |  TEARSCIENCE, INC.   |  PALVELLA THERAPEUTICS, INC.   |  KADENWOOD LLC   |  KADENWOOD, INC.   |  CAROMONT PARTNERS, LLC   |  SIGNING DAY SPORTS, INC.   |  QENTA INC.   |  RAD GOLF, INC.   |  BEETLEJUICE FIRST NATIONAL TOUR LLC   |  CHROMOCELL THERAPEUTICS CORP   |  PELTHOS THERAPEUTICS INC.
EZRA 
 
FRIEDBERG 
DIRECTOR
MULTIPLIER CAPITAL, LP   |  MULTIPLIER GROWTH PARTNERS SPV I, LP   |  KALOBIOS PHARMACEUTICALS INC   |  MULTIPLIER CAPITAL II, LP   |  HUMANIGEN, INC   |  MULTIPLIER CAPITAL III, LP   |  CHROMOCELL THERAPEUTICS CORP   |  PELTHOS THERAPEUTICS INC.
PETER 
 
GREENLEAF 
DIRECTOR
RIB X PHARMACEUTICALS INC   |  CORRIDOR PHARMACEUTICALS, INC.   |  HISTOGENICS CORP   |  EYEGATE PHARMACEUTICALS INC   |  PELTHOS THERAPEUTICS INC.
FRANCIS 
 
KNUETTEL 
EXECUTIVE OFFICER
SCWORX CORP.   |  180 LIFE SCIENCES CORP.   |  ETHEROS PHARMACEUTICALS CORP.   |  CHROMOCELL THERAPEUTICS CORP
FRANCIS 
 
KNUETTEL II 
EXECUTIVE OFFICER
IP COMMERCE INC   |  MARATHON PATENT GROUP, INC.   |  SPINDLE, INC.   |  MJAR HOLDINGS CORP.   |  TERRA TECH CORP.   |  UNRIVALED BRANDS, INC.   |  ETHEROS PHARMACEUTICALS CORP.   |  PELTHOS THERAPEUTICS INC.
ERIC 
 
LANG 
EXECUTIVE OFFICER
CHROMOCELL THERAPEUTICS CORP   |  CYTOGEL PHARMA, LLC
RICHARD 
 
MALAMUT 
DIRECTOR
CHROMOCELL THERAPEUTICS CORP   |  PELTHOS THERAPEUTICS INC.
MATTHEW 
 
PAULS 
DIRECTOR
CORTENDO AB   |  STRONGBRIDGE BIOPHARMA PLC   |  EGALET CORP   |  SAVARA INC   |  AMPLO BIOTECHNOLOGY, INC.   |  SOLENO THERAPEUTICS INC   |  PELTHOS THERAPEUTICS INC.
SCOTT 
 
PLESHA 
EXECUTIVE OFFICER, DIRECTOR
PELTHOS THERAPEUTICS INC.
SAI 
 
RANGARAO 
EXECUTIVE OFFICER
PELTHOS THERAPEUTICS INC.
CHIA-LIN 
 
SIMMONS 
DIRECTOR
LOOKY LOO, INC.   |  CHROMOCELL THERAPEUTICS CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-19
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2025-11-06 
2025-07-10
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-07-01 
2024-08-06
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2024-07-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#